CJC-1295 & Ipamorelin Blend (10mg)

CJC‑1295 & Ipamorelin Peptide Blend

CJC‑1295 and Ipamorelin are synthetic peptides that are commonly used as reference materials in laboratory and in‑vitro research. This blend contains CJC‑1295 (NO DAC) and Ipamorelin in a lyophilized powder format suitable for qualified research settings only.​

Structural and Physicochemical Information

CJC‑1295 is a synthetic analog corresponding to a fragment of growth hormone–releasing hormone (GHRH 1‑29) with several amino acid substitutions designed to alter its stability. Ipamorelin is a synthetic pentapeptide that has been characterized as a growth hormone secretagogue analog in the scientific literature.​

• Molecular formula (CJC‑1295): C152H252N44O42​

• Molecular weight (CJC‑1295): 3367.9 g/mol​

• Molecular formula (Ipamorelin): C38H49N9O5​

• Molecular weight (Ipamorelin): 711.8 g/mol​

• Other designations:

  • CJC‑1295: “CJC‑1295 NO DAC”, “Mod GRF 1‑29”​

  • Ipamorelin: “NNC 26‑0161”​

Intended Use and Limitations

This material is supplied strictly for research use only (RUO), including laboratory, in‑vitro, and analytical applications by trained professionals in appropriately equipped facilities. It is not a drug, food, cosmetic, or dietary supplement, and is not intended for human or veterinary use, clinical applications, or any form of in‑vivo administration.​

No claims are made regarding any biological effect, performance outcome, or therapeutic use in humans or animals. Any literature or references cited are provided solely to support basic scientific context and characterization, and must not be interpreted as recommendations for use.​

Quality and Documentation

Each batch is accompanied by a Certificate of Analysis (COA) detailing identity, purity, and related analytical data generated using established methods such as HPLC and mass spectrometry. Researchers should review the COA and any available quality documentation to determine suitability for their specific experimental protocols.